Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
- 1 January 2008
- journal article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 3 (4), 450-459
- https://doi.org/10.4244/eijv3i4a81
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 24 references indexed in Scilit:
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- A Cause for ConcernCirculation, 2007
- Late Stent ThrombosisCirculation, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort studyThe Lancet, 2007
- Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel DiseaseJournal of the American College of Cardiology, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004
- Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the arterial revascularisation therapies study part II (ARTS II)Heart, 2004
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001